Circulating tumor DNA methylation detection as biomarker and its application in tumor liquid biopsy: advances and challenges

Citations Over TimeTop 1% of 2024 papers

Abstract

Circulating tumor DNA (ctDNA) methylation, an innovative liquid biopsy biomarker, has emerged as a promising tool in early cancer diagnosis, monitoring, and prognosis prediction. As a noninvasive approach, liquid biopsy overcomes the limitations of traditional tissue biopsy. Among various biomarkers, ctDNA methylation has garnered significant attention due to its high specificity and early detection capability across diverse cancer types. Despite its immense potential, the clinical application of ctDNA methylation faces substantial challenges pertaining to sensitivity, specificity, and standardization. In this review, we begin by introducing the basic biology and common detection techniques of ctDNA methylation. We then explore recent advancements and the challenges faced in the clinical application of ctDNA methylation in liquid biopsies. This includes progress in early screening and diagnosis, identification of clinical molecular subtypes, monitoring of recurrence and minimal residual disease (MRD), prediction of treatment response and prognosis, assessment of tumor burden, and determination of tissue origin. Finally, we discuss the future perspectives and challenges of ctDNA methylation detection in clinical applications. This comprehensive overview underscores the vital role of ctDNA methylation in enhancing cancer diagnostic accuracy, personalizing treatments, and effectively monitoring disease progression, providing valuable insights for future research and clinical practice.

Related Papers

• → Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis(2020)152 cited
• → Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions(2015)71 cited
• → Combination of microfluidic chips and biosensing for the enrichment of circulating tumor cells(2022)30 cited
• → Exploration of Circulating Tumour Cell (CTC) Biology: A Paradigm Shift in Liquid Biopsy(2020)19 cited
• → Clinical Applications of Circulating Tumor Cells in Pharmacotherapy: Challenges and Perspectives(2017)16 cited